Skip to main content

Table 3 The tissue to blood ratios of boron concentrations under the continuous-infusion protocol

From: Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy

 

Intestine

Liver

Kidney

Lung

Tongue

Skin

Muscle

Brain

Tumour

L-BPA (μg/g)

1.22 ± 0.13

0.90 ± 0.09

3.80 ± 1.21

1.18 ± 0.01

1.17 ± 0.167

1.02 ± 0.38

0.93 ± 0.06

0.37 ± 0.05

1.58 ± 0.20

L-FBPA (μg/g)

1.17 ± 0.04

1.18 ± 0.19

4.40 ± 1.04

1.12 ± 0.03

1.03 ± 0.152

0.92 ± 0.01

0.74 ± 0.09

0.35 ± 0.15

1.52 ± 0.42

p value

0.46

0.11

0.52

0.048

0.33

0.65

0.044

0.80

0.85